mRNA-Based Engineering of Viral Antigen-Specific TCR-T Cells.

Area of Science:

• Immunology
• Cell Therapy
• Molecular Biology

Background:

• T cell receptor-engineered T cells (TCR-T) redirect T cells to target specific cells.
• Engineering T cells ex vivo involves expressing antigen-specific TCRs.
• Current methods may involve permanent genetic modification.

Purpose of the Study:

• To provide a streamlined laboratory protocol for generating specific TCR-T cell therapy products.
• To highlight the advantages of mRNA electroporation for transient modification.
• To present methods for evaluating TCR-T cell functionality.

Main Methods:

• Generating autologous mRNA-electroporated TCR-T cells.
• Incorporating viral antigen specificity and immunosuppressive drug resistance (IDRA).
• Developing protocols for in vitro and in vivo functionality assessment.

Main Results:

• A streamlined protocol for IDRA TCR-T cell generation was established.
• Transient mRNA electroporation was favored over permanent genetic modification.
• Protocols for functional evaluation were presented.

Conclusions:

• The described protocol offers an efficient method for producing specialized TCR-T cell therapy products.
• Transient mRNA electroporation presents advantages for specific TCR-T applications.
• Comprehensive evaluation methods ensure the functionality of the generated TCR-T cells.